Drug Database
Back to search

Poland· PL-100446945

Akineton

A biperiden product containing biperideni hydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC N04AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAkinetonATCN04AA02REGISTER NO.PL-100446945PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about biperideni hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Biperiden is registered in 15 of 19 countries.

Countries holding a registration under ATC N04AA02 (biperiden), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search biperiden products by name

Biperiden · ATC N04AA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of biperiden costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.28 in France to $1.58 in Switzerland — a ×5.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Biperiden · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.58
  • IT Italy$0.36
  • FR France$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Biperideni hydrochloridum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
N04AA02
ATC class
Biperiden
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991447311

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for biperiden.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check biperiden against other medicinesHow interaction checks work

Biperiden · interactions on record

89 records

  • 3 severe
  • 85 moderate
  • 1 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Biperiden in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All biperiden products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Akineton
  • Belgium · Akineton
  • Bulgaria · Акинестат, Акинетон
  • Cyprus · Akineton Retard
  • Czechia · Akineton
  • Germany · Akineton, Biperiden Neuraxpharm
  • Denmark · Akineton
  • Spain · Akinetón, Akinetón Retard
  • Finland · Akineton
  • France · Akineton L.P.
  • Greece · Akineton
  • Croatia · Akineton, Mendilex
  • Hungary · Akineton
  • Ireland · Akineton, Akineton Retard
  • Iceland · Akineton
  • Italy · Akineton
  • Luxembourg · Akineton
  • Netherlands · Akineton
  • Norway · Akineton
  • Portugal · Akineton, Akineton Retard
  • Sweden · Akineton
  • Slovenia · Akineton
  • Slovakia · Akineton, Akineton Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9467ede-e09f-4a00-90f5-b8ec99c827a9
GET /v1/drugs/c9467ede-e09f-4a00-90f5-b8ec99c827a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909991447311 ¦ Rp ¦ 139115\n50 tabl.",
  "substance": "Biperideni hydrochloridum 2 mg",
  "common_name": "Biperideni hydrochloridum",
  "pl_product_id": "100446945",
  "pozwolenie_nr": "33/21",
  "auth_procedure": "IR",
  "authorisation_validity": "2026-01-28"
}
API referenceMCP serverPlans

See everything about biperiden.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console